Literature DB >> 24495448

Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.

Patrick N Espiritu1, Einar F Sverrisson1, Wade J Sexton1, Julio M Pow-Sang1, Michael A Poch1, Jasreman Dhillon2, Philippe E Spiess3.   

Abstract

OBJECTIVE: To identify predictors of recurrence-free survival (RFS) based on the clinicopathological features of patients with upper tract urothelial carcinoma (UTUC) who have undergone radical nephroureterectomy (RNU) with bladder cuff resection.
MATERIALS AND METHODS: We retrospectively reviewed the records of patients from October 1998 to July 2012 at our tertiary institution and identified 120 patients with sufficient data who underwent RNU for UTUC. We recorded various clinical and histopathological parameters as potential predictors of outcome. Recurrence was defined as any occurrence of urothelial carcinoma after RNU either intravesically, local/regionally, or at distant sites. Univariate, multivariate, and RFS analyses were conducted using the Cox regression and Kaplan-Meier methods.
RESULTS: The median age of our cohort was 71 years (interquartile range: 64-78). Median RNU-specimen tumor size was 3.0 cm (interquartile range: 2.0-5.0 cm). Fifty-four patients (45%) had a tumor<3.0 cm and 66 (55%) had a tumor≥3.0 cm. Eighty patients (66.7%) had organ-confined UTUC (≤pT2) and 40 (33.3%) had non-organ-confined UTUC (≥pT3). Sixty-five patients (54.2%) experienced at least 1 recurrence. Forty-three patients (35.8%) had at least 1 episode of intravesical recurrence and 28 (23.3%) had distant recurrence. A multivariate analysis revealed non-organ-confined disease (hazard ratio [HR] = 3.62, P<0.001), tumor diameter≥3 cm (HR = 1.97, P = 0.011), and male gender (HR = 1.81, P = 0.047) to be significant independent predictors of disease recurrence. The 5-year RFS rate was 46.9% and 25.8% for patients with tumor size<3 and ≥3 cm, respectively.
CONCLUSIONS: Following RNU, the incidence of recurrence remains high among patients with UTUC. In our cohort of patients, tumor diameter≥3.0 cm, non-organ-confined UTUC, and male gender constitute important risk factors for poor RFS outcomes following RNU. These patients require diligent postoperative surveillance and may potentially benefit from perioperative systemic therapy.
© 2014 Published by Elsevier Inc.

Entities:  

Keywords:  Pathology; Recurrence; Risk factors; Tumor size; Upper tract urothelial carcinoma

Mesh:

Year:  2014        PMID: 24495448     DOI: 10.1016/j.urolonc.2013.11.006

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  13 in total

1.  [Impact of diagnostic ureteroscopy and biopsy on radical nephroureterectomy of upper tract urothelial carcinoma].

Authors:  R Z Ma; H Z Xia; M Lu; Z Y Zhang; Q M Zhang; J Lu; G L Wang; L L Ma
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

Review 2.  Gender differences in incidence and outcomes of urothelial and kidney cancer.

Authors:  Ilaria Lucca; Tobias Klatte; Harun Fajkovic; Michela de Martino; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2015-10       Impact factor: 14.432

3.  Treatment strategies for upper tract urothelial carcinoma (UTUC) of a solitary kidney: a single-institutional analysis of 61 cases.

Authors:  Xiaohong Su; Dong Fang; Lei Zhang; Gengyan Xiong; Han Hao; Guangzhi Zhao; Kunlin Yang; Yunchao Xing; Xuesong Li; Liqun Zhou
Journal:  Int Urol Nephrol       Date:  2016-07-04       Impact factor: 2.370

4.  The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.

Authors:  Minyong Kang; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

5.  Predictors of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: an inflammation-based prognostic score.

Authors:  Yang Hyun Cho; Young Ho Seo; Seung Jun Chung; Insang Hwang; Ho Song Yu; Sun-Ouck Kim; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park; Jun Eul Hwang; Suk Hee Heo; Geun Soo Kim; Eu Chang Hwang
Journal:  Korean J Urol       Date:  2014-07-11

6.  The Influence of Tumor Size on Oncologic Outcomes for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy.

Authors:  Xiaohong Su; Dong Fang; Xuesong Li; Gengyan Xiong; Lei Zhang; Han Hao; Yanqing Gong; Zheng Zhang; Liqun Zhou
Journal:  Biomed Res Int       Date:  2016-12-14       Impact factor: 3.411

7.  Prognostic significance of urothelial carcinoma with divergent differentiation in upper urinary tract after radical nephroureterectomy without metastatic diseases: A retrospective cohort study.

Authors:  Chuan Qin; En-Li Liang; Zhi-Yong Du; Xiao-Yu Qiu; Gang Tang; Fei-Ran Chen; Bo Zhang; Da-Wei Tian; Hai-Long Hu; Chang-Li Wu
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

8.  Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysis.

Authors:  Chengzhuo Li; Didi Han; Qiao Huang; Fengshuo Xu; Shuai Zheng; Xiang Li; Fanfan Zhao; Xiaojie Feng; Jun Lyu
Journal:  BMJ Open       Date:  2021-07-19       Impact factor: 2.692

9.  Effects of tumor size and location on survival in upper tract urothelial carcinoma after nephroureterectomy.

Authors:  Shreyas S Joshi; Laura L Quast; Sam S Chang; Sanjay G Patel
Journal:  Indian J Urol       Date:  2018 Jan-Mar

10.  Diagnostic and prognostic role of BTA, NMP22, survivin and cytology in urothelial carcinoma.

Authors:  Yu-Wen Gong; Yi-Ran Wang; Guang-Rui Fan; Qian Niu; You-Li Zhao; Hanzhang Wang; Robert Svatek; Ronald Rodriguez; Zhi-Ping Wang
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.